Episode 399: A PD1/VEGF Bispecific in Lung Cancer - Lessons for GU Cancers?

John Heymach, MD, PhD, joins the show to discuss a novel PD1/VEGF bispecific agent in lung cancer and its potential applications in GU malignancies. Dr. Heymach serves as the Chair of Thoracic/Head and Neck Medical Oncology at MD Anderson Cancer Center, and holds the David Bruton Endowed Chair in Cancer Research.